A Memorandum of Understanding was arrived at between India and Netherlands for development of vaccines.
- The MoU signed under ‘Make in India’ initiative of Government of India will enable the Bharat Immunologicals and Biologicals Corporation Ltd (BIBCOL), a Central PSU under Department of Biotechnology, to develop Measles – Rubella vaccine at its plant at Chola, Bulandshahr, U.P. Translational Vaccinology (INTRAVACC) a government-based institute of the Netherlands will extend technical support for the development of vaccine.
- Under the MoU cooperation in development of other vaccines and biologicals with DBT Research Institutes shall be explored.
Bharat Immunologicals and Biological Corporation Limited (BIBCOL), Bulandshahar, UP is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science & Technology, Government of India. BIBCOL was established as a PSU in 1989, with the aim to achieve self-sufficiency for the nation with respect to production and supply of high quality polio vaccine and other biologicals.
Measles is a highly contagious, serious disease caused by a virus. The disease remains one of the leading causes of death among young children globally, despite the availability of a safe and effective vaccine.
- Measles is caused by a virus in the paramyxovirus family and it is normally passed through direct contact and through the air. It is an airborne disease. It may also be spread through contact with saliva or nasal secretions.
- The virus infects the mucous membranes, and then spreads throughout the body. Measles is a human disease and is not known to occur in animals.
- Approximately 145 700 people died from measles in 2013 – mostly children under the age of 5.
- Initial signs and symptoms typically include fever, cough, runny nose, and red eyes. Two or three days after the start of symptoms, small white spots may form inside the mouth, known as Koplik’s spots. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms.
- Accelerated immunization activities have had a major impact on reducing measles deaths. During 2000-2013, measles vaccination prevented an estimated 15.6 million deaths. Global measles deaths have decreased by 75% from an estimated 544 200 in 2000 to 145 700 in 2013.
- Unvaccinated young children are at highest risk of measles and its complications, including death. Unvaccinated pregnant women are also at risk. Any non-immune person (who has not been vaccinated or was vaccinated but did not develop immunity) can become infected.
Sources: The Hindu, Wiki.